How we manage blood product support and coagulation in the adult patient requiring extracorporeal membrane oxygenation. Issue 4 (16th February 2022)

• Record Type: Journal Article
• Authors: Kelly, Daniel P.; Grandin, Edward Wilson; O'Brien, Kerry L.
• Is Part Of: Transfusion. Volume 62:Issue 4(2022)
• Page Start: 741
• Page End: 750
• Publication Date: 2022-02-16
• Subjects: ECMO -- extracorporeal -- transfusion support; Hematology -- Periodicals; Blood -- Transfusion -- Periodicals; Blood Group Antigens -- Periodicals; Blood Preservation -- Periodicals; Blood Transfusion -- Periodicals; 615
• DOI: 10.1111/trf.16830
• Languages: English
• ISSNs: 0041-1132

Abstract

Abstract: Use of extracorporeal membrane oxygenation (ECMO) is increasing among critically ill adults with cardiac and/or respiratory failure. Use of ECMO is associated with hemostatic alterations requiring use of anticoagulation and blood product support. There are limited guidelines to direct transfusion management in the adult patient supported with ECMO. The objective of this article is to describe (1) the role of the transfusion service in providing transfusion support and current understanding of transfusion thresholds, (2) the complexities of monitoring anticoagulation, and (3) the consideration regarding additional factor concentrates and antifibrinolytics within the context of ECMO support. The information provided should assist ECMO care teams in informing transfusion and anticoagulation practice while highlighting key areas for future research and collaboration.